Study Name: Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
35 locations found
- 1237.5.01038 Boehringer Ingelheim Investigational Site
Location: Jasper, Alabama
- 1237.5.01036 Boehringer Ingelheim Investigational Site
Location: Mobile, Alabama
- 1237.5.01015 Boehringer Ingelheim Investigational Site
Location: Boulder, Colorado
- 1237.5.01024 Boehringer Ingelheim Investigational Site
Location: Wheat Ridge, Colorado
- 1237.5.01034 Boehringer Ingelheim Investigational Site
Location: Stamford, Connecticut
- 1237.5.01003 Boehringer Ingelheim Investigational Site
Location: Clearwater, Florida
- 1237.5.01010 Boehringer Ingelheim Investigational Site
Location: Clearwater, Florida
- 1237.5.01027 Boehringer Ingelheim Investigational Site
Location: Panama City, Florida
- 1237.5.01031 Boehringer Ingelheim Investigational Site
Location: O'Fallon, Illinois
- 1237.5.01035 Boehringer Ingelheim Investigational Site
Location: Opelousas, Louisiana
- 1237.5.01004 Boehringer Ingelheim Investigational Site
Location: Shreveport, Louisiana
- 1237.5.01017 Boehringer Ingelheim Investigational Site
Location: Biddeford, Maine
- 1237.5.01028 Boehringer Ingelheim Investigational Site
Location: Columbia, Maryland
- 1237.5.01013 Boehringer Ingelheim Investigational Site
Location: Livonia, Michigan
- 1237.5.01019 Boehringer Ingelheim Investigational Site
Location: Omaha, Nebraska
- 1237.5.01025 Boehringer Ingelheim Investigational Site
Location: Larchmont, New York
- 1237.5.01008 Boehringer Ingelheim Investigational Site
Location: Rochester, New York
- 1237.5.01023 Boehringer Ingelheim Investigational Site
Location: Raleigh, North Carolina
- 1237.5.01016 Boehringer Ingelheim Investigational Site
Location: Tabor City, North Carolina
- 1237.5.01039 Boehringer Ingelheim Investigational Site
Location: Centerville, Ohio
- 1237.5.01006 Boehringer Ingelheim Investigational Site
Location: Cincinnati, Ohio
- 1237.5.01040 Boehringer Ingelheim Investigational Site
Location: Columbus, Ohio
- 1237.5.01037 Boehringer Ingelheim Investigational Site
Location: Toledo, Ohio
- 1237.5.01009 Boehringer Ingelheim Investigational Site
Location: Oklahoma City, Oklahoma
- 1237.5.01032 Boehringer Ingelheim Investigational Site
Location: Charleston, Pennsylvania
- 1237.5.01005 Boehringer Ingelheim Investigational Site
Location: Johnston, Rhode Island
- 1237.5.01021 Boehringer Ingelheim Investigational Site
Location: Easley, South Carolina
- 1237.5.01012 Boehringer Ingelheim Investigational Site
Location: Gaffney, South Carolina
- 1237.5.01014 Boehringer Ingelheim Investigational Site
Location: Spartanburg, South Carolina
- 1237.5.01029 Boehringer Ingelheim Investigational Site
Location: Ft. Worth, Texas
- 1237.5.01002 Boehringer Ingelheim Investigational Site
Location: San Antonio, Texas
- 1237.5.01026 Boehringer Ingelheim Investigational Site
Location: Lynchburg, Virginia
- 1237.5.01007 Boehringer Ingelheim Investigational Site
Location: Spokane, Washington
- 1237.5.01033 Boehringer Ingelheim Investigational Site
Location: Tacoma, Washington
- 1237.5.01001 Boehringer Ingelheim Investigational Site
Location: Morgantown, West Virginia
|